Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix
- 1 January 2002
- journal article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 5, 52-56
- https://doi.org/10.1016/s1472-6483(11)60217-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III studyHuman Reproduction, 2000
- Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelinHuman Reproduction, 2000
- Pregnancies achieved after frozen–thawed pronuclear oocytes obtained by intracytoplasmic sperm injection with spermatozoa extracted from frozen–thawed testicular tissues from non-obstructive azoospermic menHuman Reproduction, 1999
- New approaches to ovarian stimulationHuman Reproduction, 1998
- Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulationFertility and Sterility, 1997
- EndocrinologyHormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)Human Reproduction, 1996
- Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosagesJournal of Assisted Reproduction and Genetics, 1996
- Comparison of cryopreservation of supernumerary pronuclear human oocytes obtained after intracytoplasmic sperm injection (ICSI) and after conventional in-vitro fertilizationHuman Reproduction, 1996
- Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulationHuman Reproduction, 1994